Skip to main content

HLN · Haleon plc · Webcasts, Transcripts & Audio

Track HLN — free
$8.78 +0.06 (+0.69%)
Market Cap
$40.72B
Shares
4.40B
Volume · Oct 2 10.13M Avg daily vol (3M) 13.13M

Haleon plc Webcasts

Earnings calls, investor updates, investor days and conferences for Haleon plc (HLN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-07-30
Haleon plc (HLN) Q2 2026 Earnings Call Transcript
Confident tone Emerging markets growth engine win-is-won strategy and medium-term guidance North America execution and recovery
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
Haleon plc (HLN) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Positive tone Emerging markets performance (India, China, LatAm, EMEA) A&P investment and innovation U.S. market weakness and cold and flu season
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Haleon plc (HLN) Q3 2025 Earnings Call Transcript
Positive tone North America softness and outlook Emerging markets (India, LatAm, APAC) Oral Health and Sensodyne
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Haleon plc (HLN) Q2 2025 Earnings Call Transcript
Balanced tone Advil and Centrum Recovery A&P Reinvestment Emerging Markets Growth
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Haleon plc (HLN) Q1 2025 Earnings Call Transcript
Positive tone Emerging markets performance Innovation and product launches Organic revenue growth and guidance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Haleon plc (HLN) Q4 2024 Earnings Call Transcript
Positive tone Oral Health and Innovation 2025 Guidance and Quarterly Phasing Emerging Markets: India and China
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-06-30
Haleon plc (HLN) Q2 2024 Earnings Call Transcript
Confident tone Eroxon launch and product innovation Category dynamics (Pain Relief, Respi, Oral Health, VMS) Margin and A&P investment in H2
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Haleon plc (HLN) Q1 2024 Earnings Call Transcript
Positive tone U.S. volume softness and retailer inventory adjustments Pain relief and respiratory comparatives Leadership transition (CFO succession)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Haleon plc (HLN) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 webcasts
Key facts CIK 1900304 CUSIP 405552100 13F (30d) 24 filings 16 filers Visit website Investor relations